PCSK9 Inhibitors: A Guide for Managed Care

Experts urge for technology-driven, collaborative solutions as patients shoulder a growing burden of prescription costs.

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

Experts emphasize the need for enhanced clinical trial infrastructure in community oncology to ensure equitable access to innovative therapies for all patients.

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

Key trends and challenges are shaping the next era of advanced therapies, from FDA momentum to broader patient access.

Respiratory diseases made up the hospitalizations in older adults after they were exposed to wildfire smoke.